Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009

Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009–2016

Published:2019-01 Issue:1 Volume:12 Page:
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ Cardiovasc Interv

Author:

Dayoub Elias J.¹²³,Nathan Ashwin S.²³⁴,Khatana Sameed Ahmed M.²³⁴,Seigerman Matthew⁴,Tuteja Sony⁵,Kobayashi Taisei¹²⁴,Kolansky Daniel M.⁴,Groeneveld Peter W.¹²³,Giri Jay¹²³⁴

Affiliation:

1. Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA (E.J.D., T.K., P.W.G., J.G.).

2. Center for Cardiovascular Outcomes, Quality, and Evaluative Research, University of Pennsylvania (E.J.D., A.S.N., S.A.M.K., T.K., P.W.G., J.G.).

3. Leonard Davis Institute of Health Economics at the University of Pennsylvania (E.J.D., A.S.N., S.A.M.K., P.W.G., J.G.).

4. Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania (A.S.N., S.A.M.K., M.S., T.K., D.M.K., J.G.)

5. Department of Medicine, Hospital of the University of Pennsylvania (S.T.)

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

2. Potent P2Y 12 Inhibitors in Low-Risk Patients

3. Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016

4. Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease

5. U.S. National Library of Medicine ClinicalTrials.gov. Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting (ALPHEUS). https://clinicaltrials.gov/ct2/show/NCT02617290. Accessed July 26 2018.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Comparison of Clopidogrel with Ticagrelor and Prasugrel In Patients with Chronic Coronary Disease undergoing Atherectomy;2023-10-25

2. Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes;EUROINTERVENTION;2023

3. Application of Pharmacogenetics for the Use of Antiplatelet and Anticoagulant Drugs;Current Cardiovascular Risk Reports;2023-01-10

4. Prasugrel and Ticagrelor Treatment Among Patients With ACS;JACC: Cardiovascular Interventions;2022-11

5. Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention;JACC: Cardiovascular Interventions;2022-11